Christopher K. Murray, CHIEF TECHNICAL OPERATIONS at Blueprint Medicines Corp (BPMC), sold 5,042 shares at $90.69 ($457K) on 2024-03-07, disclosed to the SEC on 2024-03-11.
Seasonal sale ($457k) by CHIEF TECHNICAL OPERATIONS — this insider has traded BPMC in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.69 | 2,521 | $229K | 50.0% |
| 2 | $90.69 | 2,521 | $229K | 50.0% |
| Total | $90.69 avg | 5,042 | $457K | 100% |
| Filing → |
| BPMC | SELL | 2023-12-11 | $375K | — | Filing → |
| BPMC | SELL | 2023-12-06 | $43K | — | Filing → |
| BPMC | SELL | 2023-10-30 | $34K | — | Filing → |